510(k) K081213
K081213 is an FDA 510(k) premarket notification submitted by Bd Biosciences for the device "BD FACSCOUNT CD4 REAGENTS WITH MODEL 339010". The FDA issued a decision of Substantially Equivalent on August 14, 2008. The device falls under product code GKZ (Counter, Differential Cell), a Class II device regulated under 21 CFR 864.5220. Bd Biosciences has at least 9 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 14, 2008
- Date Received
- April 30, 2008
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Counter, Differential Cell
- Device Class
- Class II
- Regulation Number
- 864.5220
- Review Panel
- HE
- Submission Type